Informations générales (source: ClinicalTrials.gov)
Biology of Cerebral Arteriovenous Malformations : Study of the Link Between Blood Biomarkers and the Haemorrhagic Prognosis of Cerebral Arteriovenous Malformations (BioMAV)
Observational
Fondation Ophtalmologique Adolphe de Rothschild (Voir sur ClinicalTrials)
novembre 2018
novembre 2028
29 juin 2024
The cerebral arteriovenous malformations correspond to the formation of an entanglement
of morphologically abnormal vessels called nidus, which shunt the blood circulation
directly from the arterial circulation to the venous circulation.
The cerebral arteriovenous malformations are an important cause of hemorrhagic stroke.
The hypothesis is that cerebral haemorrhage associated with a cerebral arteriovenous
malformations would come from peri-nidal micro-vessels, in connection with infiltration
of leucocytes and / or defective maintenance of microvascular integrity by platelets.
Etablissements
| Les établissements d'Île-de-France ayant mis à jour leurs données Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| HOPITAL FONDATION A. DE ROTHSCHILD | Jean-Philippe DESILLES | 09/01/2025 10:42:05 | Contacter | ||
| Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| Fondation Ophtalmologique Rotschild - 75019 - Paris - France | Dr Jean-Philippe DESILLES | Contact (sur clinicalTrials) | |||
Critères
Tous
Inclusion Criteria:
- Patient over 18 years old
- Patient with a cerebral AVM for which an intervention (endovascular treatment or
surgery) or only clinical monitoring
- Express consent to participate in the study
And
- children
- Free informed and express consent of both holders of the minor patient's parental
authority, or, by way of derogation and only if the other holder of parental
authority cannot give his or her consent within a time limit compatible with the
methodological requirements specific to the conduct of the research with regard to
its purposes, of one of the two holders of parental authority
- Patient over 18 years old
- Patient with a cerebral AVM for which an intervention (endovascular treatment or
surgery) or only clinical monitoring
- Express consent to participate in the study
And
- children
- Free informed and express consent of both holders of the minor patient's parental
authority, or, by way of derogation and only if the other holder of parental
authority cannot give his or her consent within a time limit compatible with the
methodological requirements specific to the conduct of the research with regard to
its purposes, of one of the two holders of parental authority
- Patient benefiting from a legal protection measure
- Pregnant or breast feeding woman